Clinical Trials Browser

Interventional × Glioblastoma × ixazomib × Clear all

NCT02630030 2021-03-26

Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma

Phase EARLY_PHASE1 Completed

3 enrolled 10 charts

Glioblastoma